Targeted inhibition of TGF-β results in an initial improvement but long-term deficit in force production after contraction-induced skeletal muscle injury

Journal of Applied Physiology

Volumn 115, Issue 4, 2013, Pages 539-545

  Gumucio, Jonathan P ^a   Flood, Michael D ^a   Anthony, C Phan ^a   Brooks, Susan V ^a   Mendias, Christopher L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Atrogin 1; Fibroblast specific protein 1; Scleraxis; Transforming growth factor

Indexed keywords

FBXO32 PROTEIN, MOUSE; MUSCLE PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE;

ANIMAL; ARTICLE; ATROGIN-1; C57BL MOUSE; CONVALESCENCE; DRUG ANTAGONISM; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBROBLAST SPECIFIC PROTEIN-1; FIBROSIS; METABOLISM; MOUSE; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE WEAKNESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCLERAXIS; SKELETAL MUSCLE; TRANSFORMING GROWTH FACTOR-Β;

ATROGIN-1; FIBROBLAST SPECIFIC PROTEIN-1; SCLERAXIS; TRANSFORMING GROWTH FACTOR-Β;

ANIMALS; EXTRACELLULAR MATRIX; FIBROSIS; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; RECOVERY OF FUNCTION; SKP CULLIN F-BOX PROTEIN LIGASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84882692064     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00374.2013     Document Type: Article

References (49)

1. Andreetta F, Bernasconi P, Baggi F, Ferro P, Oliva L, Arnoldi E, Cornelio F, Mantegazza R, Confalonieri P. Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy. J Neuroimmunol 175: 77-86, 2006.
2. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 116: 217-224, 2003.
3. Bedair HS, Karthikeyan T, Quintero A, Li Y, Huard J. Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am J Sports Med 36: 1548-1554, 2008.
4. Brinckmann J. Collagens at a glance. Collagen 1-6, 2005.
5. Brockett CL, Morgan DL, Proske U. Predicting hamstring strain injury in elite athletes. Med Sci Sports Exercise 36: 379-387, 2004.
6. Brooks SV, Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404: 71-82, 1988.
7. Burks TN, Andres-Mateos E, Marx R, Mejias R, Van Erp C, Simmers JL, Walston JD, Ward CW, Cohn RD. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia (Abstract). Sci Trans Med 3: 82ra37, 2011.
8. Calve S, Isaac J, Gumucio JP, Mendias CL. Hyaluronic acid, HAS1, and HAS2 are significantly upregulated during muscle hypertrophy. Am J Physiol Cell Physiol 303: C577-C588, 2012.
9. Chan YS. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med 33: 43-51, 2005.
10. Dasch JR, Pace DR, Waegell W, Inenaga D, Ellingsworth L. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J Immunol 142: 1536-1541, 1989.
11. Docheva D, Hunziker EB, Fässler R, Brandau O. Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol 25: 699-705, 2005.
12. Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limón P. The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol 10: 554-567, 2010.
13. Ge X, Vajjala A, McFarlane C, Wahli W, Sharma M, Kambadur R. Lack of Smad3 signaling leads to impaired skeletal muscle regeneration. Am J Physiol Endocrinol Metab 303: E90-E102, 2012.
14. Hayashi H, Sakai T. Biological significance of local TGF- activation in liver diseases (Abstract). Frontiers Physiol 3: 12, 2012.
15. Järvinen TAH, Järvinen TLN, Kääriäinen M, Aärimaa V, Vaittinen S, Kalimo H, Järvinen M. Muscle injuries: optimising recovery. Best practice & research. Clin Rheumatol 21: 317-331, 2007.
16. Järvinen TAH, Järvinen TLN, Kääriäinen M, Kalimo H, Järvinen M. Muscle injuries: biology and treatment. Am J Sports Med 33: 745-764, 2005.
17. Joe AWB, Yi L, Natarajan A, Le Grand F, So L, Wang J, Rudnicki MA, Rossi FMV. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 12: 153-163, 2010.
18. Kobayashi T, Uehara K, Ota S, Tobita K, Ambrosio F, Cummins JH, Terada S, Fu FH, Huard J. The timing of administration of a clinically relevant dose of losartan influences the healing process after contusion induced muscle injury. J Appl Physiol 114: 262-273, 2013.
19. Koh TJ, Pizza FX. Do inflammatory cells influence skeletal muscle hypertrophy? Front Biosci 1: 60-71, 2009.
20. Kujala UM, Orava S, Järvinen M. Hamstring injuries. Sports Med 23: 397-404, 1997.
21. Leask A, Abraham DJ. TGF- signaling and the fibrotic response. 18: 816-827, 2004.
22. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J, Huard J. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: A key event in muscle fibrogenesis. Am J Pathol 164: 1007-1019, 2004.
23. Li Y, Fu FH, Huard J. Cutting-edge muscle recovery: using antifibrosis agents to improve healing. Phys Sports Med 33: 44-50, 2005.
24. Lockhart NC, Brooks SV. Neutrophil accumulation following passive stretches contributes to adaptations that reduce contraction-induced skeletal muscle injury in mice. J Appl Physiol 104: 1109-1115, 2008.
25. Maeda T, Sakabe T, Sunaga A, Sakai K, Rivera AL, Keene DR, Sasaki T, Stavnezer E, Iannotti J, Schweitzer R. Conversion of mechanical force into TGF- -mediated biochemical signals. Curr Biol 21: 933-941, 2011.
26. Mahoney DJ, Carey K, Fu MH, Snow R, Cameron-Smith D, Parise G, Tarnopolsky MA. Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiol Genomics 18: 226-231, 2004.
27. Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, Pessina P, Serrano AL, Muñoz-Cánoves P. Aberrant repair and fibrosis development in skeletal muscle (Abstract). Skelet Muscle 1: 21, 2011.
28. McCully KK, Faulkner JA. Injury to skeletal muscle fibers of mice following lengthening contractions. J Appl Physiol 59: 119-126, 1985.
29. Mendias CL, Gumucio JP, Bakhurin KI, Lynch EB, Brooks SV. Physiological loading of tendons induces scleraxis expression in epitenon fibroblasts. J Orthopaedic Res 30: 606-612, 2011.
30. Mendias CL, Gumucio JP, Davis ME, Bromley CW, Davis CS, Brooks SV. Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis. Muscle Nerve 45: 55-59, 2012.
31. Mendias CL, Gumucio JP, Lynch EB. Mechanical loading and TGFbeta change the expression of multiple miRNAs in tendon fibroblasts. J Appl Physiol 113: 56-62, 2012.
32. Mendias CL, Marcin JE, Calerdon DR, Faulkner JA. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiology 101: 898-905, 2006.
33. Middaugh CR, Mach H, Burke CJ, Volkin DB, Dabora JM, Tsai PK, Bruner MW, Ryan JA, Marfia KE. Nature of the interaction of growth factors with suramin. Biochemistry 31: 9016-9024, 1992.
34. Mishra DK, Fridén J, Schmitz MC, Lieber RL. Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg 77: 1510-1519, 1995.
35. Murphy MM, Lawson JA, Mathew SJ, Hutcheson DA, Kardon G. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 138: 3625-3637, 2011.
36. Nakanishi H, Sugiura T, Streisand JB, Lonning SM, Roberts JD. TGF-beta-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am J Physiol Lung Cell Mol Physiol 293: L151-L161, 2007.
37. Nissim A, Chernajovsky Y. Historical development of monoclonal antibody therapeutics. Handbook Exp Pharmacol 3-18, 2008.
38. Nozaki M, Ota S, Terada S, Li Y, Uehara K, Gharaibeh B, Fu FH, Huard J. Timing of the administration of suramin treatment after muscle injury. Muscle Nerve 46: 70-79, 2012.
39. Okada H, Ban S, Nagao S, Takahashi H, Suzuki H, Neilson EG. Progressive renal fibrosis in murine polycystic kidney disease: An immunohistochemical observation. Kidney Int 58: 587-597, 2000.
40. Pryce BA, Watson SS, Murchison ND, Staverosky JA, Dunker N, Schweitzer R. Recruitment and maintenance of tendon progenitors by TGF signaling are essential for tendon formation. Development 136: 1351-1361, 2009.
41. Rader EP, Faulkner JA. Recovery from contraction-induced injury is impaired in weight-bearing muscles of old male mice. J Appl Physiol 100: 656-661, 2006.
42. Ramaswamy KS, Palmer ML, van der Meulen JH, Renoux A, Kostrominova TY, Michele DE, Faulkner JA. Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats. J Physiol 589: 1195-1208, 2011.
43. Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology 23: 160-170, 2008.
44. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protocols 3: 1101-1108, 2008.
45. Schmittgen TD, Zakrajsek BA. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RTPCR. J Biochem Biophys Methods 46: 69-81, 2000.
46. Smith C, Kruger MJ, Smith RM, Myburgh KH. The inflammatory response to skeletal muscle injury: Illuminating complexities. Sports Med 38: 947-969, 2008.
47. Smith CA, Stauber F, Waters C, Alway SE, Stauber WT. Transforming growth factor-beta following skeletal muscle strain injury in rats. J Appl Physiol 102: 755-761, 2007.
48. Tsukada S, Westwick JK, Ikejima K, Sato N, Rippe RA. SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-betastimulated hepatic stellate cells. J Biol Chem 280: 10055-10064, 2005.
49. Yingling JM, Blanchard KL, Sawyer JS. Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Disc 3: 1011-1022, 2004.